Literature DB >> 35115668

Defibrotide-treated patients with anicteric or icteric veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic cell transplantation: an EBMT study.

Mohamad Mohty1, Thomas Cluzeau2, Charlotte Jubert3, Sarah Lawson4, Robert J Ryan5, Raj Hanvesakul6, Katia Perruccio7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35115668     DOI： 10.1038/s41409-022-01588-8

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program.

Authors:  Selim Corbacioglu; Enric Carreras; Mohamad Mohty; Antonio Pagliuca; Jaap Jan Boelens; Gandhi Damaj; Massimo Iacobelli; Dietger Niederwieser; Eduardo Olavarría; Felipe Suarez; Tapani Ruutu; Leo Verdonck; Robin Hume; Bijan Nejadnik; Chinglin Lai; Giorgia Finetto; Paul Richardson
Journal:  Biol Blood Marrow Transplant       Date:  2016-07-07       Impact factor: 5.742

2.  Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

Authors:  Selim Corbacioglu; Simone Cesaro; Maura Faraci; Dominique Valteau-Couanet; Bernd Gruhn; Attilio Rovelli; Jaap J Boelens; Annette Hewitt; Johanna Schrum; Ansgar S Schulz; Ingo Müller; Jerry Stein; Robert Wynn; Johann Greil; Karl-Walter Sykora; Susanne Matthes-Martin; Monika Führer; Anne O'Meara; Jacek Toporski; Petr Sedlacek; Paul G Schlegel; Karoline Ehlert; Anders Fasth; Jacek Winiarski; Johan Arvidson; Christine Mauz-Körholz; Hulya Ozsahin; Andre Schrauder; Peter Bader; Joseph Massaro; Ralph D'Agostino; Margaret Hoyle; Massimo Iacobelli; Klaus-Michael Debatin; Christina Peters; Giorgio Dini
Journal:  Lancet       Date:  2012-02-23       Impact factor: 79.321

Review 3.  Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement.

Authors:  Kris M Mahadeo; Rajinder Bajwa; Hisham Abdel-Azim; Leslie E Lehmann; Christine Duncan; Nicole Zantek; Jennifer Vittorio; Joseph Angelo; Jennifer McArthur; Keri Schadler; Sherwin Chan; Priti Tewari; Sajad Khazal; Jeffery J Auletta; Sung Won Choi; Basirat Shoberu; Krzysztof Kalwak; Avis Harden; Partow Kebriaei; Jun-Ichi Abe; Shulin Li; Jerelyn Roberson Moffet; Susan Abraham; Francesco Paolo Tambaro; Katharina Kleinschmidt; Paul G Richardson; Selim Corbacioglu
Journal:  Lancet Haematol       Date:  2019-12-07       Impact factor: 18.959

Review 4.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.

Authors:  Jason A Coppell; Paul G Richardson; Robert Soiffer; Paul L Martin; Nancy A Kernan; Allen Chen; Eva Guinan; Georgia Vogelsang; Amrita Krishnan; Sergio Giralt; Carolyn Revta; Nicole A Carreau; Massimo Iacobelli; Enric Carreras; Tapani Ruutu; Tiziano Barbui; Joseph H Antin; Dietger Niederwieser
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-18       Impact factor: 5.742

5.  Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.

Authors:  K Yakushijin; Y Atsuta; N Doki; A Yokota; H Kanamori; T Miyamoto; C Ohwada; K Miyamura; Y Nawa; M Kurokawa; I Mizuno; T Mori; M Onizuka; J Taguchi; T Ichinohe; H Yabe; Y Morishima; K Kato; R Suzuki; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2015-11-23       Impact factor: 5.483

6.  Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.

Authors:  S Corbacioglu; E Carreras; M Ansari; A Balduzzi; S Cesaro; J-H Dalle; F Dignan; B Gibson; T Guengoer; B Gruhn; A Lankester; F Locatelli; A Pagliuca; C Peters; P G Richardson; A S Schulz; P Sedlacek; J Stein; K-W Sykora; J Toporski; E Trigoso; K Vetteranta; J Wachowiak; E Wallhult; R Wynn; I Yaniv; A Yesilipek; M Mohty; P Bader
Journal:  Bone Marrow Transplant       Date:  2017-07-31       Impact factor: 5.483

Review 7.  Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Francesca Bonifazi; Francesco Barbato; Federico Ravaioli; Mariarosaria Sessa; Irene Defrancesco; Mario Arpinati; Michele Cavo; Antonio Colecchia
Journal:  Front Immunol       Date:  2020-04-03       Impact factor: 7.561

Review 8.  Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation.

Authors:  Gerhard C Hildebrandt; Nelson Chao
Journal:  Br J Haematol       Date:  2020-04-21       Impact factor: 6.998

9.  Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.

Authors:  Nancy A Kernan; Stephan Grupp; Angela R Smith; Sally Arai; Brandon Triplett; Joseph H Antin; Leslie Lehmann; Tsiporah Shore; Vincent T Ho; Nancy Bunin; Massimo Iacobelli; Wei Liang; Robin Hume; William Tappe; Robert Soiffer; Paul Richardson
Journal:  Br J Haematol       Date:  2018-05-16       Impact factor: 6.998

10.  Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients.

Authors:  Selim Corbacioglu; Nancy A Kernan; Antonio Pagliuca; Robert J Ryan; William Tappe; Paul G Richardson
Journal:  Biol Blood Marrow Transplant       Date:  2020-03-19       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.